Inactive Instrument

Exactus Inc Share Price OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

18/11	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/24/06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	5L 5L 4L 4L 7L 4.95Cr 7L 49.65L 19.45L 2.47Cr 19.49L 19.06L 8.14Cr	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	2.2Cr 1.92Cr 1.79Cr 1.64Cr 3.1Cr 210.16Cr 3.15Cr 21Cr 8.26Cr 104.8Cr 8.28Cr 8.1Cr 345.67Cr	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

18/11	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/24/06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/24/01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/24/01	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
05/23/05	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
02/23/02	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
30/23/30	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
02/23/02	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
10/23/10	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
10/23/10	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

18/11	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
16/24/16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
16/24/16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
05/23/05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
02/23/02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-2.39%	-6.36%	+47.10%	+149.66%	1LCr
JOHNSON & JOHNSON	-0.76%	-4.34%	+52.04%	+49.09%	61TCr
ABBVIE INC.	-2.33%	-4.60%	+25.55%	+64.44%	43TCr
ROCHE HOLDING AG	+0.68%	-1.14%	+38.47%	+33.36%	35TCr
NOVARTIS AG	-1.66%	-3.13%	+32.18%	+39.79%	29TCr
ASTRAZENECA PLC	-8.96%	-10.77%	+3.57%	+5.50%	24TCr
NOVO NORDISK A/S	-1.37%	-7.41%	-2.10%	-43.67%	21TCr
AMGEN INC.	-1.63%	+0.69%	+27.62%	+64.23%	20TCr
GILEAD SCIENCES, INC.	+0.72%	+0.48%	+15.88%	+73.64%	16TCr
Average	-1.54%	-3.88%	+26.70%	+48.45%	38.89TCr
Weighted average by Cap.	-0.93%	-4.34%	+34.73%	+70.96%

	2022	2023
Net sales	16.27L 14.14L 13.2L 12.12L 22.85L 16Cr 23.25L 1.56Cr 60.96L 7.73Cr 61.11L 59.76L 26Cr	23.85L 20.73L 19.35L 17.77L 33.5L 23Cr 34.08L 2.28Cr 89.37L 11Cr 89.58L 87.6L 37Cr
Net income	-91.43L -79.46L -74.18L -68.1L -1.28Cr -87Cr -1.31Cr -8.75Cr -3.43Cr -43Cr -3.43Cr -3.36Cr -143.34Cr	-80.15L -69.66L -65.04L -59.7L -1.13Cr -76Cr -1.15Cr -7.67Cr -3Cr -38Cr -3.01Cr -2.94Cr -125.66Cr
Net Debt	1.79Cr 1.55Cr 1.45Cr 1.33Cr 2.51Cr 170.17Cr 2.55Cr 17Cr 6.69Cr 85Cr 6.71Cr 6.56Cr 279.91Cr	2.15Cr 1.87Cr 1.75Cr 1.6Cr 3.02Cr 205.21Cr 3.08Cr 21Cr 8.07Cr 102.34Cr 8.09Cr 7.91Cr 337.54Cr

Exactus Inc Share Price OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile